Estimating the Long-Term Treatment Benefits of Sacubitril-Valsartan

被引:95
作者
Claggett, Brian [1 ]
Packer, Milton [2 ]
McMurray, John J. V. [3 ]
Swedberg, Karl [4 ]
Rouleau, Jean [5 ]
Zile, Michael R. [6 ]
Jhund, Pardeep [3 ]
Lefkowitz, Martin [7 ]
Shi, Victor [7 ]
Solomon, Scott D. [1 ]
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Baylor Univ, Med Ctr, Dallas, TX USA
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Gothenburg Univ, Gothenburg, Sweden
[5] Univ Montreal, Montreal, PQ, Canada
[6] Med Univ S Carolina, Charleston, SC 29425 USA
[7] Novartis, E Hanover, NJ USA
关键词
HEART-FAILURE; ENALAPRIL; SURVIVAL;
D O I
10.1056/NEJMc1509753
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2289 / 2290
页数:2
相关论文
共 5 条
[1]   Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism [J].
Glynn, RJ ;
Rosner, B .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2005, 162 (10) :975-982
[2]  
Korn EL, 1997, AM J EPIDEMIOL, V145, P72
[3]   Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure [J].
McMurray, John J. V. ;
Packer, Milton ;
Desai, Akshay S. ;
Gong, Jianjian ;
Lefkowitz, Martin P. ;
Rizkala, Adel R. ;
Rouleau, Jean L. ;
Shi, Victor C. ;
Solomon, Scott D. ;
Swedberg, Karl ;
Zile, Michael R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :993-1004
[4]   Moving Beyond the Hazard Ratio in Quantifying the Between-Group Difference in Survival Analysis [J].
Uno, Hajime ;
Claggett, Brian ;
Tian, Lu ;
Inoue, Eisuke ;
Gallo, Paul ;
Miyata, Toshio ;
Schrag, Deborah ;
Takeuchi, Masahiro ;
Uyama, Yoshiaki ;
Zhao, Lihui ;
Skali, Hicham ;
Solomon, Scott ;
Jacobus, Susanna ;
Hughes, Michael ;
Packer, Milton ;
Wei, Lee-Jen .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (22) :2380-U138